Results
eNauka >
Rezultati >
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial
| Naziv: | Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial | Autori  : | Mansfield, AS; ...; Andric, Zoran G   ; ...; (broj, koautora 19) |
Godina: | 2020 | Publikacija: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 31 br. 2 str. 310-317 | DOI: | 10.1016/j.annonc.2019.10.021 | WoS-ID: | 000516712400020 | Scopus-ID: | 2-s2.0-85078578106 | URI: | https://enauka.gov.rs/handle/123456789/811739 | Projekat: | F. Hoffmann-La Roche Ltd, Basel, SwitzerlandHoffmann-La Roche | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.